Aridis Pharmaceuticals Inc
ARDS
Market Cap$44.57K
Close$
$-0.07
66900% downside
Current Fair Value
66900% downsideOvervalued by 66900% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $44,574.00 |
|---|---|
| Enterprise Value | $1.82 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.64 |
| Beta | 1.1 |
| Outstanding Shares | 37,428,943 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.09 |
| Enterprise Value to EBIT | -1.93 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -0.08 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aridis Pharmaceuticals Inc
33 employeesAridis Pharmaceuticals, Inc. discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ?PEXTM and MabIgX® technology platforms to rapidly identify rar...